Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. Keeping that in mind, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where analysts may be overlooking some important risks.

Two Stocks to Sell:

Purple (PRPL)

Consensus Price Target: $2.53 (250% implied return)

Founded by two brothers, Purple (NASDAQ: PRPL) creates sleep and home comfort products such as mattresses, pillows, and bedding accessories.

Why Do We Steer Clear of PRPL?

1. Annual revenue declines of 5.3% over the last five years indicate problems with its market positioning
2. Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
3. Unfavorable liquidity position could lead to additional equity financing that dilutes shareholders

At $0.72 per share, Purple trades at 17.4x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including PRPL in your portfolio.

Stewart Information Services (STC)

Consensus Price Target: $81.50 (21.7% implied return)

Founded in 1893 during America's westward expansion when property records were often disputed, Stewart Information Services (NYSE: STC) provides title insurance and real estate services, helping homebuyers, sellers, and lenders verify property ownership and protect against title defects.

Why Does STC Fall Short?

1. 2.9% annualized net premiums earned growth over the last five years lagged behind its insurance peers
2. Incremental sales over the last five years were much less profitable as its earnings per share fell by 2.8% annually while its revenue grew
3. Annual book value per share growth of 3.2% over the last two years was below our standards for the insurance sector

Stewart Information Services’s stock price of $67.00 implies a valuation ratio of 1.2x forward P/B. To fully understand why you should be careful with STC, check out our full research report (it’s free).

One Stock to Watch:

Boston Scientific (BSX)

Consensus Price Target: $124.41 (35.6% implied return)

Founded in 1979 with a mission to advance less-invasive medicine, Boston Scientific (NYSE: BSX) develops and manufactures medical devices used in minimally invasive procedures across cardiovascular, urological, neurological, and gastrointestinal specialties.

Why Do We Like BSX?

1. Average organic revenue growth of 16.2% over the past two years demonstrates its ability to expand independently without relying on acquisitions
2. Incremental sales over the last five years have been highly profitable as its earnings per share increased by 19.9% annually, topping its revenue gains
3. Free cash flow margin increased by 5.5 percentage points over the last five years, giving the company more capital to invest or return to shareholders

Boston Scientific is trading at $91.75 per share, or 27.6x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.